BHV-7000 Acute Treatment of Bipolar Mania
NCT06419582 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 274
Last updated 2025-12-16
Summary
The purpose of this study is to determine whether BHV-7000 is a safe and effective acute treatment for manic episodes in bipolar disorder I.
Conditions
Interventions
- DRUG
-
BHV-7000
BHV-7000 75 mg taken once daily for 21 days
- DRUG
-
Matching placebo taken once daily for 21 days
Sponsors & Collaborators
-
Biohaven Therapeutics Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-05-28
- Primary Completion
- 2025-01-15
- Completion
- 2025-01-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
NCT06462612 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
NCT06951711 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913 ·Status: RECRUITING ·Phase: PHASE3
-
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes, Associated With Bipolar I Disorder
NCT03257865 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01822678 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Assess Brexpiprazole Versus Placebo for the Treatment of Acute Manic Episodes Associated With Bipolar I Disorder
NCT03259555 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
NCT02670538 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
NCT06605599 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273 ·Status: RECRUITING ·Phase: PHASE3
-
An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
NCT00060905 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.
NCT06429722 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of the Safety and Efficacy of Memantine in Patients With Acute Mania Associated With Bipolar I Disorder
NCT00106405 ·Status: COMPLETED ·Phase: PHASE2
-
Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder
NCT05025605 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess the Adverse Events of Oral ABBV-932 in Adult Participants With Depressive Episodes Associated With Bipolar I or II Disorder
NCT07220460 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Elpipodect (MK-8189) in Participants With Bipolar I Disorder (MK-8189-020)
NCT06273774 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests Whether BI 409306 Prevents Patients With a Specific Type of Mental Illness (Attenuated Psychosis Syndrome) From Becoming Worse. This Study Looks at How Well Patients Tolerate the Medicine and How Effective it is Over 1 Year
NCT03230097 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
NCT06024239 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study of Oral Cariprazine Capsules to Assess Change in Disease Activity in Adult Participants With Bipolar I Disorder
NCT06256367 ·Status: COMPLETED
-
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
NCT05658510 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) in Acute Manic Episodes Associated With Bipolar I Disorder
NCT01824602 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Brenipatide in Adult Participants With Bipolar Disorder (RENEW-Bipolar-1)
NCT07286175 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
NCT00812058 ·Status: COMPLETED ·Phase: PHASE2
-
Aripiprazole in Patients With Acute Mania
NCT00095511 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Participants With Bipolar I Disorder.
NCT03287869 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder
NCT00107939 ·Status: COMPLETED ·Phase: PHASE3